BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) is a biopharmaceutical company that is developing treatments for infectious diseases and other illnesses. Recently, BiondVax signed definitive agreements ...
VHH antibodies, they’re not just small, they're modular engineering platforms, capable of powerful biological activity. But ...
Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor. Cell and gene ...
Dr. Dave Fancy discusses the common challenges that scientists face when developing nanobodies and how anti-alpaca secondary antibodies can be used to produce high-affinity nanobodies and VHH ...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, announced today that a late ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today published on the successful ...
Camelid single-domain antibodies pack high affinity and exceptional stability into a footprint of about fifteen kilodaltons. They reach grooves that full IgGs cannot, tolerate harsh process conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results